The intricate mechanism of PLS3 in bone homeostasis and disease
Open accessThe DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Abstract
Since our discovery in 2013 that genetic defects in PLS3 lead to bone fragility, the mechanistic details of this process have remained obscure. It has been established that PLS3 variants cause syndromic and nonsyndromic osteoporosis as well as osteoarthritis. PLS3 codes for an actin-bundling protein with a broad pattern of expression. As such, it is puzzling how PLS3 specifically leads to bone-related disease presentation. Our review aims to summarize the current state of knowledge regarding the function of PLS3 in the predominant cell types in the bone tissue, the osteocytes, osteoblasts and osteoclasts. This is related to the role of PLS3 in regulating mechanotransduction, calcium regulation, vesicle trafficking, cell differentiation and mineralization as part of the complex bone pathology presented by PLS3 defects. Considering the consequences of PLS3 defects on multiple aspects of bone tissue metabolism, our review motivates the study of its mechanism in bone diseases which can potentially help in the design of suitable therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PLS3 functions by altering osteocyte function through an abnormal cytoskeletal microarchitecture and bone mineralization [42,43].”
From Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics (2023) · cites this paper as [42]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“PLS3 is another recently identified gene that is linked to early-onset osteoporosis.”
From Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics (2023) · cites this paper as [42]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Stöckl, S., Göttl, C., Grifka, J., & Grässel, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350089 · Cited by 4,656
Glyn-Jones, S., Palmer, A. J. R., Agricola, R., Price, A. J., Vincent, T. L., Weinans, H., & Carr, A. J. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60802-3 · Cited by 3,151
Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J.-I., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00369-6 · Cited by 2,701 · cited 1×
“NFkB signaling is a master regulatory pathway in osteoclastogenesis; it is initiated by the binding of NFkB ligand (RANK-L) to the RANK receptor on the surface of osteoclasts to activate the transcription of nuclear factor activated T cells c1 (Nfatc1), a key transcription factor regulating osteoclastogenesis (94).”
BackgroundEndocrine regulation of energy metabolism by the skeleton
Lee, N. K., Sowa, H., Hinoi, E., Ferron, M., Ahn, J. D., Confavreux, C., Dacquin, R., Mee, P. J., McKee, M. D., Jung, D. Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.047 · Cited by 2,554 · cited 1×
“This may affect the mechanical loading perception of osteoblasts which in turn can affect the production of osteocalcin (92) and FGFs (93), involved in calcium homeostasis and bone mineralization.”
BackgroundWNT signaling in bone homeostasis and disease: From human mutations to treatments
Baron, R., & Kneissel, M. (2013) · Nature Medicine · doi:10.1038/nm.3074 · Cited by 2,093
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
Cosman, F., Crittenden, D. B., Adachi, J. D., Binkley, N., Czerwinski, E., Ferrari, S., Hofbauer, L. C., Lau, E., Lewiecki, E. M., Miyauchi, A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607948 · Cited by 1,805 · cited 1×
“DKK1, sclerostin, an inhibitor of the WNT signaling pathway, and FGF23 are primarily secreted by the osteocytes (67, 68).”
BackgroundOsteogenesis imperfecta: Clinical diagnosis, nomenclature and severity assessment
Van Dijk, F. S., & Sillence, D. O. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36545 · Cited by 795
Sensitivity of osteocytes to biomechanical stress in vitro
Klein‐Nulend, J., Van Der Plas, A., Semeins, C. M., Ajubi, N. E., Erangos, J. A., Nijweide, P. J., & Burger, E. H. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.5.7896017 · Cited by 783 · cited 1×
“Mechanical loading of bone triggers interstitial fluid flow through the lacuno-canalicular system, which causes shear stress to the osteocyte dendrites ultimately generating cellular signals (48, 49).”
BackgroundRobling, A. G., & Bonewald, L. F. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034332 · Cited by 539
Research works printed but not linked: 1
- Hosseinibarkooie, 2017, Identification and characterization of molecular pathways underlying the modifier function of plastin 3 in neurodegenerative disorders
Cited by
Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics
Adejuyigbe, B., Kallini, J., Chiou, D., & Kallini, J. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914583 · Cited by 148
“PLS3 functions by altering osteocyte function through an abnormal cytoskeletal microarchitecture and bone mineralization [42,43].”
Osteogenesis imperfecta: shifting paradigms in pathophysiology and care in children
Stasek, S., Zaucke, F., Hoyer‐Kuhn, H., Etich, J., Reincke, S., Arndt, I., Rehberg, M., & Semler, O. (2024) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2024-0512 · Cited by 8
Functional Insights in PLS3-Mediated Osteogenic Regulation
Zhong, W., Neugebauer, J., Pathak, J. L., Li, X., Pals, G., Zillikens, M. C., Eekhoff, E. M. W., Bravenboer, N., Zhang, Q., Hammerschmidt, M., et al. (2024) · Cells · doi:10.3390/cells13171507 · Cited by 4
“As previously stated, the ABD protein structure of PLS3 is essential in the regulation of actin dynamics in processes of cell motility, focal adhesion, cell division, endocytosis, vesicle trafficking, and motor axon outgrowth [3,27].”
BackgroundSelf-citationMaus, I., Dreiner, M., Zetzsche, S., Metzen, F., Ross, B. C., Mählich, D., Koch, M., Niehoff, A., & Wirth, B. (2024) · JBMR Plus · doi:10.1093/jbmrpl/ziad009 · Cited by 2
“23 However, it remains elusive, how PLS3 mutations cause osteoporosis and which cellular pathways and cell systems are mainly involved.”
Zhong, Z., Lin, J., Wu, W., Feng, W., Yuan, Z., Wu, Z., Ma, J., Wang, H., Liang, G., Xie, W., et al. (2025) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2025.102492 · Cited by 2
Metadata
- Authors
- Zhong, W., Pathak, J. L., Liang, Y., Zhytnik, L., Pals, G., Eekhoff, E. M. W., Bravenboer, N., & Micha, D.
- Affiliations
- Amsterdam Movement Sciences (NL)
- Guangzhou Medical University (CN)
- Peking University Cancer Hospital (CN)
- Amsterdam Reproduction Development (NL)
- Corresponding author
- Micha, Dimitra
- ORCID
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2023-07-07
- Volume
- 14
- Pages
- 1168306-1168306
- ISSN
- 1664-2392 (ISSN-L)
- PMC
- PMC10361617
- OpenAlex
- W4383533447
- Cited by
- 13
- References
- 129
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 4 · 2023: 2
- FWCI
- 0.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Endocrinology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Eesti Teadusagentuur (PUTJD1009)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
- Keywords
- PLS3, bone homeostasis, osteoporosis, osteoarthritis, bone fragility, actin-bundling protein, osteocytes, osteoblasts, osteoclasts, mechanotransduction, calcium regulation, vesicle trafficking, cell differentiation, bone mineralization, bone disease
- MeSH terms
- Bone and Bones, Homeostasis, Humans, Mutation, Osteoporosis, Mechanotransduction, Cellular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The intricate mechanism of PLS3 in bone homeostasis and disease. https://app.cochat.ai/papers/10.3389/fendo.2023.1168306
- The paper
- Zhong, W., Pathak, J. L., Liang, Y., Zhytnik, L., Pals, G., Eekhoff, E. M. W., Bravenboer, N., & Micha, D. (2023). The intricate mechanism of PLS3 in bone homeostasis and disease. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2023.1168306
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.